|
|
News for Healthier Living
New study of bacterial genome could lead to better TB drugs
Rockefeller researchers created the first comprehensive map of interactions among genes essential to the survival of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis. To enable the study, the team refined a CRISPRi-based platform they initially developed for tuning gene expression, extending it to support large-scale perturbation of gene pairs. Their platform has already revealed four new synergistic drug combinations and predicts dozens more, offering scientists a new path to combat antibiotic resistance.
November 4, 2026
November 4 2026November 3 2026November 2 2026November 1 2026October 30 2026October 29 2026October 28 2026October 27 2026October 26 2026October 25 2026October 24 2026October 23 2026October 22 2026October 21 2026
|
|
|
|
|